Stock search

Ticker or company name

Compare stocks

Market: US

  • BMYBristol Myers Squibb
  • VTRSViatris
  • ZTSZoetis

Add stock

Ticker or company

Summary

BMY
Bristol Myers Squibb
$62,93Down −0,79%
Year: Up +30%
81/100Best scoreRatio would consider buying
Open stock page
VTRS
Viatris
$20,74Down −0,38%
Year: Up +91%
36/100Ratio would not consider buying
Open stock page
ZTS
Zoetis
$84,39Up +0,68%
Year: Down −31%
75/100Ratio would consider buying
Open stock page

Verdict

BMY has the best score (81). VTRS grows revenue the fastest. VTRS is the cheapest by forward P/E. ZTS has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckBMY5 ✓ 3 — 0 ✕VTRS2 ✓ 1 — 4 ✕ZTS5 ✓ 2 — 1 ✕
P/E vs its history14,0—12,4
P/E vs industry14,0—12,4
Forward P/E9,5n/a7,112,4
Revenue growth, YoY+4,2%+4,3%+1,2%
EPS growth, YoY+52,4%—−1,0%
Net margin18,5%n/a—26,1%
Net debt / EBITDAn/a—3,5n/a—
Free cash flow$9,29 bn$2,11 bn$2,28 bn
Share count over a year+0,7%−1,4%−7,1%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterBMYTTMVTRSTTMZTSTTMIndustry medianTTM
P/E TTM ↓Worst: 14,0n/aBest: 12,441,8
Forward P/E ↓9,5Best: 7,1Worst: 12,412,4
PEG ↓−4,3n/a2,03,3
P/S TTM ↓2,6Best: 1,6Worst: 3,43,4
EV/EBITDA ↓Best: 11,4Worst: 12,611,824,0
P/FCF ↓Worst: 14,0Best: 11,813,714,0

Price, %

  • BMYn/a
  • VTRSn/a
  • ZTSn/a

Returns

Best WorstNo mark — in between

PeriodBMYVTRSZTS
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

BMYVTRSZTS
Share of “buy”41%Best: 67%Worst: 41%
Beat the forecastBest: 4 of 4Best: 4 of 4Worst: 2 of 4
Average “surprise”Best: +16,6%+10,5%Worst: +3,2%
Insiders over 12 monthssales $2,53 msales $1,09 msales $1,65 m

Details are on each stock page.